GLP|1 drugs expected to drive up employer health spending in 2025

GLP-1 drugs expected to drive up employer health spending in 2025

Health plan costs are expected to rise by 8% in 2025, driven in part by GLP-1 drugs · Nearly one-half of employers surveyed by WTW said they ...

Large employers forecast 7.8% hike in health costs next year, thanks ...

The rising burden of pharmaceuticals is expected to be the primary driver of rising healthcare spending in 2025, mostly due to expensive ...

Weight loss drugs fuel large employers' healthcare cost concerns for ...

Large employers expect healthcare costs will be 50% higher in 2025 than in 2017, and prescription drug spending — including for · GLP-1 drugs ...

Business Group on Health Survey Reveals Almost 8% in Projected ...

GLP-1 medications, a top driver of pharmacy costs, have created challenges for employers. Some 79% of employers said they saw a heightened interest in obesity ...

Employer Health Costs Set to Spike Upward in 2025 | INSURICA

A major culprit behind escalating health expenses is the surging cost of specialty medications, particularly GLP-1 drugs like Ozempic and Wegovy ...

GLP-1s partly to blame for spike in health insurance costs in 2025

But the group also noted that costs have grown a cumulative 50% since 2017. Spending on drugs and treatments is driving up costs — from 21% of ...

Employers Project 8%-9% Rise in Health Care Costs for 2025 - SHRM

The other big trend pushing employer health care costs higher is the use of pricey GLP-1 (glucagon-like peptide-1) drugs, such as Ozempic and Wegovy, which have ...

Employer health benefits costs likely to soar again in 2025

In addition to GLP-1 medications, expensive gene and cellular therapies contributed to the 7.2% increase in drug benefit costs per employee in ...

Your employer may start covering weight-loss drugs soon - CNN

Workers are eligible for the GLP-1 medications for obesity treatment at 67% of the large companies in the Business Group on Health's 2024 report ...

Survey: Employers expect third year of high health cost growth in 2025

Spending on prescription drugs remains the fastest-growing component of health benefit cost; employers reported that drug benefit cost per ...

From GLP-1 Drugs To Catastrophic Claims – Why Employer Health ...

Increased adoption of GLP-1 drugs, rising catastrophic claims and other cost pressures are driving employer-sponsored health insurance costs to ...

Rising pharmacy costs cause pain for employers: survey

Growing demand for pricey medications, including glucagon-like peptide-1 agonists, cancer treatments, and cell and gene therapies, has employers ...

Report Finds Weight Loss Drugs Key Driver of 2025 Health Care ...

A recent Business Group on Health (BGH) survey found that heightened interest and spending on glucagon-like peptide-1(GLP-1) drugs is a major driver of rising ...

Obesity Drugs Will Get Broad Commercial Coverage In 2025 ...

A strong majority of employers responding to the latest Business Group on Health health care strategy survey said they will cover GLP-1 drugs for obesity in ...

Employer Healthcare Costs Projected to Hit 10-Year High in 2025

Inflation, · Heightened demand for expensive drugs such as glucagon-like peptide-1 (GLP-1), · Potentially curative but high-cost cell and gene ...

Medical cost trend: Behind the numbers 2025 - PwC

The costs of GLP-1 drugs are on a rising trajectory that impacts overall medical costs. Innovation in prescription drugs for chronic conditions and increasing ...

Employers expect third consecutive year of health benefit cost ...

Mr. Patel said, “While we've seen significant increases in utilization in a few areas, such as for behavioral healthcare and GLP-1 medications, ...

Employers expect 2025 health care cost trends to rise 8%

About 57% of the 118 employer benefits decisionmakers who answered a question about cost drivers classified GLP-1 agonist spending as "driving ...

Workplace insurance could soon be stripped down - Axios

56% of employers specifically identified GLP-1s as driving up health costs by a "very great" or "great" extent, and 46% say other high-cost ...

Employer healthcare spending forecast to rise in 2025 - HR Executive

Pharmacy costs, including expensive GLP-1 drugs and pricey cell and gene therapies, are the main drivers of employer healthcare spending.